SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Charpentier Abigail

(Last) (First) (Middle)
ARAMARK
2400 MARKET STREET

(Street)
PHILADELPHIA PA 19103

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2023
3. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP & Chief HR Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 23,436.185(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (2) 09/01/2031 Common Stock 16,169 $35.24 D
Stock Option (Right to Buy) (3) 11/18/2031 Common Stock 9,037 $36.89 D
Stock Option (Right to Buy) (4) 11/17/2032 Common Stock 7,057 $40.29 D
Explanation of Responses:
1. Includes 3,842.158 restricted stock units which will vest in two equal annual installments on September 1, 2023 and 2024; 2,936.027 restricted stock units which will vest in two equal annual installments on November 18, 2023 and 2024; and 3,972 restricted stock units which will vest in four equal annual installments on November 17, 2023, 2024, 2025 and 2026.
2. Represents stock options, 5,389 of which have fully vested, 5,390 which will vest on September 1, 2023, and 5,390 which will vest on September 1, 2024.
3. Represents stock options, 3,012 of which have fully vested, 3,012 which will vest on November 18, 2023, and 3,013 which will vest on November 18, 2024.
4. Represents stock options, 1,764 which will vest on November 17, 2023, 1,764 which will vest on November 17, 2024, 1,764 which will vest on November 17, 2025, and 1,765 which will vest on November 17, 2026.
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Harold B. Dichter, as Attorney-in-fact 01/09/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.